Surface Oncology Q2 EPS $(0.46) Misses $(0.34) Estimate
Portfolio Pulse from Benzinga Newsdesk
Surface Oncology reported Q2 losses of $(0.46) per share, missing the analyst consensus estimate of $(0.34) by 35.29 percent. This is unchanged from the same period last year.
August 04, 2023 | 10:59 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Surface Oncology's Q2 earnings per share missed analyst estimates by 35.29%, which could negatively impact the stock price.
Earnings reports are a key indicator of a company's financial health. Missing analyst estimates, especially by a significant margin like 35.29%, can lead to a decrease in investor confidence and a potential drop in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100